aluates Reports

$ 0.0

Automative

Global Fibromyalgia Drugs Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-20C2902

Global Fibromyalgia Drugs Market Insights and Forecast to 2028

BUY CHAPTERS

Global Fibromyalgia Drugs Market Research Report 2025

Code: QYRE-Auto-20C2902

Report

September 2025

Pages:81

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

Eli Lilly

Actavis

Merck Sharp and Dohme

Daiichi Sankyo

Innovative Med Concepts

MEDA Co.

Meiji Seika

Switch Biotech

Theravance Inc

Zynerba Pharmaceuticals

Tonix Pharmaceuticals Holding Corp. (TNXP)

Fibromyalgia Drugs Market Size

The global market for Fibromyalgia Drugs was valued at US$ 2965 million in the year 2024 and is projected to reach a revised size of US$ 3342 million by 2031, growing at a CAGR of 1.8% during the forecast period.

Fibromyalgia Drugs Market

Fibromyalgia (FM) is a medical condition characterised by chronic widespread pain and a heightened pain response to pressure.

The APAC is a major untapped market with many leading vendors in the global fibromyalgia drugs market.

This report aims to provide a comprehensive presentation of the global market for Fibromyalgia Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fibromyalgia Drugs.

The Fibromyalgia Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Fibromyalgia Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Fibromyalgia Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Fibromyalgia Drugs Market Report

Report Metric	Details
Report Name	Fibromyalgia Drugs Market
Accounted market size in year	US$ 2965 million
Forecasted market size in 2031	US$ 3342 million
CAGR	1.8%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Serotonin Norepinephrine Reuptake Inhibitors GABA Analogs Other
Segment by Application	Hospitals Clinics Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Eli Lilly, Actavis, Merck Sharp and Dohme, Daiichi Sankyo, Innovative Med Concepts, Meda, Meiji Seika, Switch Biotech, Theravance, Zynerba Pharmaceuticals, Tonix Pharmaceuticals Holding Corp. (TNXP)
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Fibromyalgia Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Fibromyalgia Drugs Market growing?

Ans: The Fibromyalgia Drugs Market witnessing a CAGR of 1.8% during the forecast period 2025-2031.

What is the Fibromyalgia Drugs Market size in 2031?

Ans: The Fibromyalgia Drugs Market size in 2031 will be US$ 3342 million.

Who are the main players in the Fibromyalgia Drugs Market report?

Ans: The main players in the Fibromyalgia Drugs Market are Pfizer, Eli Lilly, Actavis, Merck Sharp and Dohme, Daiichi Sankyo, Innovative Med Concepts, Meda, Meiji Seika, Switch Biotech, Theravance, Zynerba Pharmaceuticals, Tonix Pharmaceuticals Holding Corp. (TNXP)

What are the Application segmentation covered in the Fibromyalgia Drugs Market report?

Ans: The Applications covered in the Fibromyalgia Drugs Market report are Hospitals, Clinics, Other

What are the Type segmentation covered in the Fibromyalgia Drugs Market report?

Ans: The Types covered in the Fibromyalgia Drugs Market report are Serotonin Norepinephrine Reuptake Inhibitors, GABA Analogs, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Fibromyalgia Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Serotonin Norepinephrine Reuptake Inhibitors

1.2.3 GABA Analogs

1.2.4 Other

1.3 Market by Application

1.3.1 Global Fibromyalgia Drugs Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Fibromyalgia Drugs Market Perspective (2020-2031)

2.2 Global Fibromyalgia Drugs Growth Trends by Region

2.2.1 Global Fibromyalgia Drugs Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Fibromyalgia Drugs Historic Market Size by Region (2020-2025)

2.2.3 Fibromyalgia Drugs Forecasted Market Size by Region (2026-2031)

2.3 Fibromyalgia Drugs Market Dynamics

2.3.1 Fibromyalgia Drugs Industry Trends

2.3.2 Fibromyalgia Drugs Market Drivers

2.3.3 Fibromyalgia Drugs Market Challenges

2.3.4 Fibromyalgia Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Fibromyalgia Drugs Players by Revenue

3.1.1 Global Top Fibromyalgia Drugs Players by Revenue (2020-2025)

3.1.2 Global Fibromyalgia Drugs Revenue Market Share by Players (2020-2025)

3.2 Global Fibromyalgia Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Fibromyalgia Drugs Revenue

3.4 Global Fibromyalgia Drugs Market Concentration Ratio

3.4.1 Global Fibromyalgia Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Fibromyalgia Drugs Revenue in 2024

3.5 Global Key Players of Fibromyalgia Drugs Head office and Area Served

3.6 Global Key Players of Fibromyalgia Drugs, Product and Application

3.7 Global Key Players of Fibromyalgia Drugs, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Fibromyalgia Drugs Breakdown Data by Type

4.1 Global Fibromyalgia Drugs Historic Market Size by Type (2020-2025)

4.2 Global Fibromyalgia Drugs Forecasted Market Size by Type (2026-2031)

5 Fibromyalgia Drugs Breakdown Data by Application

5.1 Global Fibromyalgia Drugs Historic Market Size by Application (2020-2025)

5.2 Global Fibromyalgia Drugs Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Fibromyalgia Drugs Market Size (2020-2031)

6.2 North America Fibromyalgia Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Fibromyalgia Drugs Market Size by Country (2020-2025)

6.4 North America Fibromyalgia Drugs Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Fibromyalgia Drugs Market Size (2020-2031)

7.2 Europe Fibromyalgia Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Fibromyalgia Drugs Market Size by Country (2020-2025)

7.4 Europe Fibromyalgia Drugs Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Fibromyalgia Drugs Market Size (2020-2031)

8.2 Asia-Pacific Fibromyalgia Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Fibromyalgia Drugs Market Size by Region (2020-2025)

8.4 Asia-Pacific Fibromyalgia Drugs Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Fibromyalgia Drugs Market Size (2020-2031)

9.2 Latin America Fibromyalgia Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Fibromyalgia Drugs Market Size by Country (2020-2025)

9.4 Latin America Fibromyalgia Drugs Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Fibromyalgia Drugs Market Size (2020-2031)

10.2 Middle East & Africa Fibromyalgia Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Fibromyalgia Drugs Market Size by Country (2020-2025)

10.4 Middle East & Africa Fibromyalgia Drugs Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Fibromyalgia Drugs Introduction

11.1.4 Pfizer Revenue in Fibromyalgia Drugs Business (2020-2025)

11.1.5 Pfizer Recent Development

11.2 Eli Lilly

11.2.1 Eli Lilly Company Details

11.2.2 Eli Lilly Business Overview

11.2.3 Eli Lilly Fibromyalgia Drugs Introduction

11.2.4 Eli Lilly Revenue in Fibromyalgia Drugs Business (2020-2025)

11.2.5 Eli Lilly Recent Development

11.3 Actavis

11.3.1 Actavis Company Details

11.3.2 Actavis Business Overview

11.3.3 Actavis Fibromyalgia Drugs Introduction

11.3.4 Actavis Revenue in Fibromyalgia Drugs Business (2020-2025)

11.3.5 Actavis Recent Development

11.4 Merck Sharp and Dohme

11.4.1 Merck Sharp and Dohme Company Details

11.4.2 Merck Sharp and Dohme Business Overview

11.4.3 Merck Sharp and Dohme Fibromyalgia Drugs Introduction

11.4.4 Merck Sharp and Dohme Revenue in Fibromyalgia Drugs Business (2020-2025)

11.4.5 Merck Sharp and Dohme Recent Development

11.5 Daiichi Sankyo

11.5.1 Daiichi Sankyo Company Details

11.5.2 Daiichi Sankyo Business Overview

11.5.3 Daiichi Sankyo Fibromyalgia Drugs Introduction

11.5.4 Daiichi Sankyo Revenue in Fibromyalgia Drugs Business (2020-2025)

11.5.5 Daiichi Sankyo Recent Development

11.6 Innovative Med Concepts

11.6.1 Innovative Med Concepts Company Details

11.6.2 Innovative Med Concepts Business Overview

11.6.3 Innovative Med Concepts Fibromyalgia Drugs Introduction

11.6.4 Innovative Med Concepts Revenue in Fibromyalgia Drugs Business (2020-2025)

11.6.5 Innovative Med Concepts Recent Development

11.7 Meda

11.7.1 Meda Company Details

11.7.2 Meda Business Overview

11.7.3 Meda Fibromyalgia Drugs Introduction

11.7.4 Meda Revenue in Fibromyalgia Drugs Business (2020-2025)

11.7.5 Meda Recent Development

11.8 Meiji Seika

11.8.1 Meiji Seika Company Details

11.8.2 Meiji Seika Business Overview

11.8.3 Meiji Seika Fibromyalgia Drugs Introduction

11.8.4 Meiji Seika Revenue in Fibromyalgia Drugs Business (2020-2025)

11.8.5 Meiji Seika Recent Development

11.9 Switch Biotech

11.9.1 Switch Biotech Company Details

11.9.2 Switch Biotech Business Overview

11.9.3 Switch Biotech Fibromyalgia Drugs Introduction

11.9.4 Switch Biotech Revenue in Fibromyalgia Drugs Business (2020-2025)

11.9.5 Switch Biotech Recent Development

11.10 Theravance

11.10.1 Theravance Company Details

11.10.2 Theravance Business Overview

11.10.3 Theravance Fibromyalgia Drugs Introduction

11.10.4 Theravance Revenue in Fibromyalgia Drugs Business (2020-2025)

11.10.5 Theravance Recent Development

11.11 Zynerba Pharmaceuticals

11.11.1 Zynerba Pharmaceuticals Company Details

11.11.2 Zynerba Pharmaceuticals Business Overview

11.11.3 Zynerba Pharmaceuticals Fibromyalgia Drugs Introduction

11.11.4 Zynerba Pharmaceuticals Revenue in Fibromyalgia Drugs Business (2020-2025)

11.11.5 Zynerba Pharmaceuticals Recent Development

11.12 Tonix Pharmaceuticals Holding Corp. (TNXP)

11.12.1 Tonix Pharmaceuticals Holding Corp. (TNXP) Company Details

11.12.2 Tonix Pharmaceuticals Holding Corp. (TNXP) Business Overview

11.12.3 Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Drugs Introduction

11.12.4 Tonix Pharmaceuticals Holding Corp. (TNXP) Revenue in Fibromyalgia Drugs Business (2020-2025)

11.12.5 Tonix Pharmaceuticals Holding Corp. (TNXP) Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Pfizer Inc

Eli Lilly

Actavis

Merck Sharp and Dohme

Daiichi Sankyo

Innovative Med Concepts

MEDA Co.

Meiji Seika

Switch Biotech

Theravance Inc

Zynerba Pharmaceuticals

Tonix Pharmaceuticals Holding Corp. (TNXP)

List of Tables

Table 1. Global Fibromyalgia Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Serotonin Norepinephrine Reuptake Inhibitors

Table 3. Key Players of GABA Analogs

Table 4. Key Players of Other

Table 5. Global Fibromyalgia Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Fibromyalgia Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Fibromyalgia Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Fibromyalgia Drugs Market Share by Region (2020-2025)

Table 9. Global Fibromyalgia Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Fibromyalgia Drugs Market Share by Region (2026-2031)

Table 11. Fibromyalgia Drugs Market Trends

Table 12. Fibromyalgia Drugs Market Drivers

Table 13. Fibromyalgia Drugs Market Challenges

Table 14. Fibromyalgia Drugs Market Restraints

Table 15. Global Fibromyalgia Drugs Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Fibromyalgia Drugs Market Share by Players (2020-2025)

Table 17. Global Top Fibromyalgia Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fibromyalgia Drugs as of 2024)

Table 18. Ranking of Global Top Fibromyalgia Drugs Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Fibromyalgia Drugs Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Fibromyalgia Drugs, Headquarters and Area Served

Table 21. Global Key Players of Fibromyalgia Drugs, Product and Application

Table 22. Global Key Players of Fibromyalgia Drugs, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Fibromyalgia Drugs Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Fibromyalgia Drugs Revenue Market Share by Type (2020-2025)

Table 26. Global Fibromyalgia Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Fibromyalgia Drugs Revenue Market Share by Type (2026-2031)

Table 28. Global Fibromyalgia Drugs Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Fibromyalgia Drugs Revenue Market Share by Application (2020-2025)

Table 30. Global Fibromyalgia Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Fibromyalgia Drugs Revenue Market Share by Application (2026-2031)

Table 32. North America Fibromyalgia Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Fibromyalgia Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Fibromyalgia Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Fibromyalgia Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Fibromyalgia Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Fibromyalgia Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Fibromyalgia Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Fibromyalgia Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Fibromyalgia Drugs Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Fibromyalgia Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Fibromyalgia Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Fibromyalgia Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Fibromyalgia Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Fibromyalgia Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Fibromyalgia Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 47. Pfizer Company Details

Table 48. Pfizer Business Overview

Table 49. Pfizer Fibromyalgia Drugs Product

Table 50. Pfizer Revenue in Fibromyalgia Drugs Business (2020-2025) & (US$ Million)

Table 51. Pfizer Recent Development

Table 52. Eli Lilly Company Details

Table 53. Eli Lilly Business Overview

Table 54. Eli Lilly Fibromyalgia Drugs Product

Table 55. Eli Lilly Revenue in Fibromyalgia Drugs Business (2020-2025) & (US$ Million)

Table 56. Eli Lilly Recent Development

Table 57. Actavis Company Details

Table 58. Actavis Business Overview

Table 59. Actavis Fibromyalgia Drugs Product

Table 60. Actavis Revenue in Fibromyalgia Drugs Business (2020-2025) & (US$ Million)

Table 61. Actavis Recent Development

Table 62. Merck Sharp and Dohme Company Details

Table 63. Merck Sharp and Dohme Business Overview

Table 64. Merck Sharp and Dohme Fibromyalgia Drugs Product

Table 65. Merck Sharp and Dohme Revenue in Fibromyalgia Drugs Business (2020-2025) & (US$ Million)

Table 66. Merck Sharp and Dohme Recent Development

Table 67. Daiichi Sankyo Company Details

Table 68. Daiichi Sankyo Business Overview

Table 69. Daiichi Sankyo Fibromyalgia Drugs Product

Table 70. Daiichi Sankyo Revenue in Fibromyalgia Drugs Business (2020-2025) & (US$ Million)

Table 71. Daiichi Sankyo Recent Development

Table 72. Innovative Med Concepts Company Details

Table 73. Innovative Med Concepts Business Overview

Table 74. Innovative Med Concepts Fibromyalgia Drugs Product

Table 75. Innovative Med Concepts Revenue in Fibromyalgia Drugs Business (2020-2025) & (US$ Million)

Table 76. Innovative Med Concepts Recent Development

Table 77. Meda Company Details

Table 78. Meda Business Overview

Table 79. Meda Fibromyalgia Drugs Product

Table 80. Meda Revenue in Fibromyalgia Drugs Business (2020-2025) & (US$ Million)

Table 81. Meda Recent Development

Table 82. Meiji Seika Company Details

Table 83. Meiji Seika Business Overview

Table 84. Meiji Seika Fibromyalgia Drugs Product

Table 85. Meiji Seika Revenue in Fibromyalgia Drugs Business (2020-2025) & (US$ Million)

Table 86. Meiji Seika Recent Development

Table 87. Switch Biotech Company Details

Table 88. Switch Biotech Business Overview

Table 89. Switch Biotech Fibromyalgia Drugs Product

Table 90. Switch Biotech Revenue in Fibromyalgia Drugs Business (2020-2025) & (US$ Million)

Table 91. Switch Biotech Recent Development

Table 92. Theravance Company Details

Table 93. Theravance Business Overview

Table 94. Theravance Fibromyalgia Drugs Product

Table 95. Theravance Revenue in Fibromyalgia Drugs Business (2020-2025) & (US$ Million)

Table 96. Theravance Recent Development

Table 97. Zynerba Pharmaceuticals Company Details

Table 98. Zynerba Pharmaceuticals Business Overview

Table 99. Zynerba Pharmaceuticals Fibromyalgia Drugs Product

Table 100. Zynerba Pharmaceuticals Revenue in Fibromyalgia Drugs Business (2020-2025) & (US$ Million)

Table 101. Zynerba Pharmaceuticals Recent Development

Table 102. Tonix Pharmaceuticals Holding Corp. (TNXP) Company Details

Table 103. Tonix Pharmaceuticals Holding Corp. (TNXP) Business Overview

Table 104. Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Drugs Product

Table 105. Tonix Pharmaceuticals Holding Corp. (TNXP) Revenue in Fibromyalgia Drugs Business (2020-2025) & (US$ Million)

Table 106. Tonix Pharmaceuticals Holding Corp. (TNXP) Recent Development

Table 107. Research Programs/Design for This Report

Table 108. Key Data Information from Secondary Sources

Table 109. Key Data Information from Primary Sources

Table 110. Authors List of This Report

List of Figures

Figure 1. Fibromyalgia Drugs Picture

Figure 2. Global Fibromyalgia Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Fibromyalgia Drugs Market Share by Type: 2024 VS 2031

Figure 4. Serotonin Norepinephrine Reuptake Inhibitors Features

Figure 5. GABA Analogs Features

Figure 6. Other Features

Figure 7. Global Fibromyalgia Drugs Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Fibromyalgia Drugs Market Share by Application: 2024 VS 2031

Figure 9. Hospitals Case Studies

Figure 10. Clinics Case Studies

Figure 11. Other Case Studies

Figure 12. Fibromyalgia Drugs Report Years Considered

Figure 13. Global Fibromyalgia Drugs Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Fibromyalgia Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Fibromyalgia Drugs Market Share by Region: 2024 VS 2031

Figure 16. Global Fibromyalgia Drugs Market Share by Players in 2024

Figure 17. Global Top Fibromyalgia Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fibromyalgia Drugs as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Fibromyalgia Drugs Revenue in 2024

Figure 19. North America Fibromyalgia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Fibromyalgia Drugs Market Share by Country (2020-2031)

Figure 21. United States Fibromyalgia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Fibromyalgia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Fibromyalgia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Fibromyalgia Drugs Market Share by Country (2020-2031)

Figure 25. Germany Fibromyalgia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Fibromyalgia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Fibromyalgia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Fibromyalgia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Fibromyalgia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Fibromyalgia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Fibromyalgia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Fibromyalgia Drugs Market Share by Region (2020-2031)

Figure 33. China Fibromyalgia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Fibromyalgia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Fibromyalgia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Fibromyalgia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Fibromyalgia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Fibromyalgia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Fibromyalgia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Fibromyalgia Drugs Market Share by Country (2020-2031)

Figure 41. Mexico Fibromyalgia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Fibromyalgia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Fibromyalgia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Fibromyalgia Drugs Market Share by Country (2020-2031)

Figure 45. Turkey Fibromyalgia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Fibromyalgia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Fibromyalgia Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Pfizer Revenue Growth Rate in Fibromyalgia Drugs Business (2020-2025)

Figure 49. Eli Lilly Revenue Growth Rate in Fibromyalgia Drugs Business (2020-2025)

Figure 50. Actavis Revenue Growth Rate in Fibromyalgia Drugs Business (2020-2025)

Figure 51. Merck Sharp and Dohme Revenue Growth Rate in Fibromyalgia Drugs Business (2020-2025)

Figure 52. Daiichi Sankyo Revenue Growth Rate in Fibromyalgia Drugs Business (2020-2025)

Figure 53. Innovative Med Concepts Revenue Growth Rate in Fibromyalgia Drugs Business (2020-2025)

Figure 54. Meda Revenue Growth Rate in Fibromyalgia Drugs Business (2020-2025)

Figure 55. Meiji Seika Revenue Growth Rate in Fibromyalgia Drugs Business (2020-2025)

Figure 56. Switch Biotech Revenue Growth Rate in Fibromyalgia Drugs Business (2020-2025)

Figure 57. Theravance Revenue Growth Rate in Fibromyalgia Drugs Business (2020-2025)

Figure 58. Zynerba Pharmaceuticals Revenue Growth Rate in Fibromyalgia Drugs Business (2020-2025)

Figure 59. Tonix Pharmaceuticals Holding Corp. (TNXP) Revenue Growth Rate in Fibromyalgia Drugs Business (2020-2025)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Medications for Fibromyalgia Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Fibromyalgia Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Fibromyalgia Therapeutics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pain Management Drugs Market Research Report 2025

Fibromyalgia Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pain Treatment Drug Market Research Report 2025

Global Drugs for Pain Management Market Insights Forecast to 2030

Global Pain Treatment Medication Market Research Report 2025

Fibromyalgia Antidepressant Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gynecological Conditions Medications Market Research Report 2024

Global Pain Management Drugs Devices Market Research Report 2025

Global Prescription Pain Medications Market Research Report 2025

Global Women s Health Care Drugs Market Research Report 2024

Medications for Chronic Pain Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Rheumatic Disorders Drug Market Insights Forecast to 2030

Global Chronic Pain Management Drugs Market Research Report 2025

Global Milnacipran Market Insights Forecast to 2030

Global Pain Management EMR Software Market Insights Forecast to 2030

Global Menopausal Medications Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions